Abbott was cleared Thursday night of allegations that its infant formula causes a potentially fatal illness, absolving the company from potentially paying $6 billion in punitive damages.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. TipRanks is the most comprehensive data set of sell side ...
Analyst Dara Mohsenian from Morgan Stanley maintained a Hold rating on Clorox (CLX – Research Report) and increased the price target to $165.00 from $154.00. Dara Mohsenian has given his Hold ...
Clorox Co (NYSE:CLX) reported strong first-quarter results, exceeding expectations and fully restoring market share following the August 2023 cyber attack. The company achieved its eighth ...
In a Thursday interview with CNBC's Jim Cramer, Clorox CEO Linda Rendle detailed how her company managed to recover after a cyberattack disrupted production and seriously hurt business.